Search the evidence

Find the signal.

Search titles, impact clusters, countries, organizations and the full text of every analysis.

Search all reporting

5 stories found

Owens et al., “Patient Perspectives on AI-Drafted Electronic Portal Messages”

This Duke/NYU-linked qualitative study of 40 patients finds that patients value AI-drafted portal replies mainly for efficiency, but their acceptance is conditional on clinician review, accountability, and disclosure. Patients did not uniformly want “more empathy”; they wanted tone, length, and detail to match the stakes of the message, with lower-stakes refills treated differently from serious clinical concerns.

Jul 7, 20262 min

A hand selects a lens beside a notebook, representing clinical checking and independent understanding.

Social good & healthGlobal+2 clusters02

A better AI answer can still need a better human check.

There is something genuinely encouraging in the new clinical reasoning study: the human check was not merely ceremonial. It helped improve the result. There is also a warning against judging a system by the right answers alone. The Nature Communications paper compares six matched pairs of reasoning and standard language models on retrospective clinical records. Reasoning models were better at including the primary diagnosis, but they also suggested more false-positive diagnoses. A separate validation exercise with fifteen physicians found benefits from structured collaboration. These are controlled retrospective findings, not proof of improved outcomes for patients in routine care. That distinction changes the design question. A longer list of plausible diagnoses can help a clinician consider something overlooked. It can also create unnecessary work if the extra possibilities are treated as conclusions. The quality of the workflow depends on how suggestions are challenged, not just how many the model can produce. The second paper, in Communications Psychology, addresses a related but different problem. Its SYNC framework separates performance with AI assistance from durable human learning. It is a Perspective proposing mechanisms and practices, not a new trial proving that a particular intervention works. I read the two together as an invitation to ask three questions. Did assistance improve the task? Were the additional errors caught? Can the person still explain and apply the reasoning without the tool later? The clinical paper offers evidence relevant to the first two. The learning framework gives a vocabulary for investigating the third. That is an editorial comparison, not a claim that one study validates the other. We can welcome useful assistance while refusing to let a polished answer stand in for either safety or understanding.

Oct 31, 20264 min

A luminous glass examination lens connects a small clinic with an amber human figure.

Social good & healthUnited States / China+1 clusters03

Medical AI can matter before it becomes a better doctor

There is something worth celebrating in an AI system that helps a person actually get a test. Two new Nature Communications studies focus attention on access and the practical work of acquiring medical information, rather than a sweeping claim that software replaces clinicians. That is a useful change of emphasis. The ACCESS2 study examined point-of-care autonomous diabetic-eye screening in 397 young people with diabetes. Screening completion reached 99.5% among White participants and 98% among non-White participants, compared with lower and more unequal prior completion. Those are encouraging access results. They do not establish that treatment was received or vision improved. The reported 100% sensitivity also has a wide 95% confidence interval of 67.6–100%; it should not be presented as diagnostic perfection. Specificity was 76%, so the downstream assessment pathway matters. A separate study evaluated an AI-guided, patient-mounted ultrasound system in 102 healthy participants and 17 patients. Its 588-gram figure describes the end-effector, not necessarily the entire system. The authors report interpretable liver images and promising acquisition performance, including field-oriented demonstrations. This is feasibility evidence, not proof that a portable robot can replace an experienced clinician across settings. The shared opportunity is concrete: reduce the distance between someone and a useful examination. My appreciation comes with a practical condition. A positive screen needs confirmation, an explanation and access to care. If the test arrives but the referral pathway does not, we may move the bottleneck rather than remove it. Still, making the first step easier is real progress worth investigating—not a consolation prize for failing to automate the whole profession.

Oct 25, 20264 min

A patient reviews clear AI-prepared questions before meeting a surgeon, with an anxiety gauge and consultation timer both falling.

Social good & healthChina+4 clusters04

A local AI briefing cut pre-surgery anxiety and physician workload

A randomized phase II study offers a bounded example of medical AI that helped without pretending to replace the clinician. Researchers assigned 268 people newly diagnosed with prostate cancer and scheduled for radical prostatectomy to standard communication or an AI-assisted pathway. The intervention used a locally deployed large language model to prepare personalized answers to patient questions before the routine face-to-face discussion. Physicians remained responsible for the encounter and were blinded to group assignment. The AI-assisted group reported a mean post-communication GAD-7 anxiety score of 3.2, compared with 5.7 in the control group. Physician workload on the NASA-TLX scale averaged 39.9 versus 56.8, and routine communication time fell from 19.9 to 11.3 minutes. Satisfaction, emotions, and illness perceptions also improved. This is stronger evidence than a product testimonial, but it is not a general verdict on AI in medicine. The study was conducted at one cancer center, used a specific preoperative setting, measured near-term outcomes, and does not establish diagnostic accuracy, surgical outcomes, or long-term safety. The trial registry also still shows an earlier estimated enrollment of 160 and future completion dates, while the published paper reports 268 randomized participants; that record mismatch should be clarified. The design’s most important feature is the boundary: the model answered common questions in advance, responses were reviewed, and the surgeon still conducted the consent conversation. AI did not replace the relationship. It gave the relationship a better starting point.

Sep 27, 202610 min

A conventional microscope with a compact motorized stage scans a bone-marrow slide and routes candidate-cell evidence to a gloved clinical reviewer.

Social good & healthUnited States and Global+3 clusters05

A low-cost self-driving microscope screens bone marrow slides for acute leukemia

A Nature Communications study presents ALLocate, a low-cost AI-powered plugin that turns a conventional microscope into a self-driving screening system for acute leukemia. The system automatically selects useful bone-marrow regions, detects cells, and produces a slide-level result without a whole-slide scanner. Researchers trained and evaluated it with more than 11,000 annotated regions and 130,000 annotated cells, then used independent multi-institutional cohorts that included 165 physical bone-marrow smear slides. Reported performance exceeded 0.99 AUROC for region selection, reached 0.90 mean average precision for cell detection, and achieved 88 percent accuracy for diagnosis on glass slides. That combination could make automated screening more accessible where scanners and specialist expertise are scarce. It does not support an autonomous final diagnosis. An 88 percent result leaves clinically important errors, and the study does not erase the need for population-specific validation, slide-quality checks, calibration, human confirmation, and escalation to a pathologist. The strongest deployment is a lower-cost bridge to expertise, not a substitute for it.

Aug 28, 20265 min